Osimertinib
19655
Phase 1 small_molecule active
Quick answer
Osimertinib for Lung Cancer Metastatic is a Phase 1 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Lung Cancer Metastatic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active